|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/28 | |
| C07K 14/705 | |||
| C07K 16/30 |
| (11) | Number of the document | 3247728 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16740686.7 |
| Date of filing the European patent application | 2016-01-20 | |
| (97) | Date of publication of the European application | 2017-11-29 |
| (45) | Date of publication and mention of the grant of the patent | 2020-04-15 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2016/014153 |
| Date | 2016-01-20 |
| (87) | Number | WO 2016/118641 |
| Date | 2016-07-28 |
| (30) | Number | Date | Country code |
| 201562105323 P | 2015-01-20 | US |
| (72) |
WANG, Beatrice Tien-Yi, US
SCHWARZER, Max Allen, US
KEYT, Bruce Alan, US
BALIGA, Ramesh, US
|
| (73) |
IGM Biosciences, Inc.,
325 E. Middlefield Rd., Mountain View, CA 94043,
US
|
| (54) | TUMOR NECROSIS FACTOR (TNF) SUPERFAMILY RECEPTOR BINDING MOLECULES AND USES THEREOF |
| TUMOR NECROSIS FACTOR (TNF) SUPERFAMILY RECEPTOR BINDING MOLECULES AND USES THEREOF |